Our blog contains short snippets from our full research coverage. We release new content regularly, so check back often for the latest insights.
We have updated our digital health market map and it is attached below. We are currently tracking over 760 companies in 23 categories across 28 countries, with a total of $15.1B in funding. To see the full list of companies, contact us using the form on www.venturescanner.com.
Exciting news! Esteemed tech accelerator Y Combinator, who has funded more than 700 startups since 2005, is for the first time actively recruiting health technology startups. This was on display at last week’s (Aug 19) demo day where one dozen health-related startups presented, marking the largest proportion of health tech companies in a Y-Combinator cohort in their nine-year history. When asked, Y-Combinator’s president Sam Altman stated, “it’s the right time for us to try health care”. This trend is echoed by many of the largest technology firms and has been rapidly gaining traction throughout the greater investment community as well. Simply put, health tech has been HOT in 2014. And to quote Mayfield Fund’s Tim Chang, “startups are finally hacking healthcare”. How? “By combining premium services with extreme convenience, engaging social networks and communities, and experimenting with information coming from the proliferation of wearable devices that are beginning to penetrate consumer markets” (his full TechCrunch guest post can be found here).That said, I’d like to take a simple look at a few macro drivers behind the current health tech movement that I feel help to better understand: Why Health + Tech? Why Now?Legislative EnvironmentTwo Acts in particular have helped drive us to rethink the way healthcare is delivered and paid for in the US. The first is the HITECH Act that was enacted as part of the American Recovery and Reinvestment Act of 2009 to “promote the adoption and meaningful use of health information technology”. This act incentivizes healthcare providers to demonstrate “meaningful use” of electronic health records by 2015 and in its wake, has spurred the entrance of a crush of startups into the health IT infrastructure space.The second is the politically charged Affordable Care Act (aka Obamacare), which, at a high-level, puts consumers back in charge of their health care and focuses on improving the quality and reach of care. The full act is a beast at roughly 1,000 pages - simplified features and rollout timeline can be found here. Many now rapidly growing healthcare companies can trace their origins to within one to two years of the ACA passage in 2010. Note: A 2014 list of these successful US health companies from Inc. can be found here.Business Environment Entrepreneurs have long recognized the upside growth potential of doing business within the healthcare industry. First, the sum that is the US healthcare ecosystem is riddled with inefficient parts that beg for an intervention making it an industry primed for tech disruption. The caveat of playing in healthcare is dealing with lots of red tape, which has long dissuaded tech entrepreneurs. Although still a very relevant consideration, this is increasingly becoming less of an entrance sticking point. Second, the US healthcare market is absolutely HUGE, equivalent to an estimated 20% of US GDP. Nearly $4 trillion is a big number and it doesn’t take a big % of market capture to excite the crowd. I cannot remember where I heard it, but to quote an unnamed source, “it is the golden age of entrepreneurship in health”; entrepreneurs are acting on opportunity, investors are placing bets and capital is flowing.Investment EnvironmentThe healthcare industry is historically a tortoise, with change occurring very slowly and it coming at high cost. This does not align with the investment strategy of a typical early-stage tech investor who prefers to hunt for hares that have the potential to scale rapidly and massively. Biotech investing, for example, involves betting on companies somewhere along the long and expensive road of drug development and FDA approvals – this is typically reserved for niche life sciences investors. Ok. So why is the “mainstream” now more interested in health? The short answer is that a new breed of health companies is increasingly leveraging computer science – including cloud processing, big data analytics and sequencing – to disrupt the healthcare regime. This aligns with Tim Chang’s comments above and has been echoed by other health tech investors including Google Ventures’ Bill Maris. For these companies (commonly known as digital health companies), the product lifecycle has shortened and costs have decreased, making them more hare-like and aligned with the tech investment archetype. The numbers back it up as US venture investment in digital health for 2014 was $2.2B+ at the half-year per Rock Health and there is no sign of slowing as investment to date is strengthening investor confidence that health tech companies can produce healthy returns.Ok, now that we’ve discussed a few “whys”, I’d like to take a quick look at some top of mind big US-based corporate “whos” that are currently playing in the health tech sandbox. Note: this is by no means an exhaustive list – just a cross-section to illustrate health’s growing reach.Large Tech CompaniesApple – launching consumer wearable health data platform, HealthKit, and partnered with other health companies including Epic (EHR) and Mayo ClinicGoogle – launching consumer wearable health data platform, Google FitSamsung – launching consumer wearable health data platform, SAMIIBM – partnered with Apple to build a suite of platforms and apps to securely transport health data to healthcare providers and EHRsMicrosoft – rumored to be improving existing consumer health data platform, HealthVault, and its Kinect device has been used in various health applicationsAmazon – company brass recently met with FDA – may be the next US tech giant to enter the market?Pharma, Biotech and Medtech CompaniesNovartis – partnered with Google on developing the “smart” contact lens and with Proteus Digital Health on furthering the development digital medicine, plus has a very active corporate VC armGenentech – CEO, Ian Clark, recently expressed interest in moving into the mobile health space for disease monitoring and has partnered with new health tech startups like PatientsLikeMeMedtronic – CEO, Omar Ishrak, recently committed to investing $10B over next decade in health tech startupsCorporate Tech VCsGoogle Ventures – health tech companies comprise a sizable portion of GV's portfolio including 23andMe, One Medical Group and Doctor on DemandQualcomm Ventures – one of the most active non-healthcare corporate venture groups with health tech investments including Practice Fusion, Fitbit and AirstripKeep your eyes on health - the future looks bright! As always, you can check out my full coverage of the digital health sector here.Devin Christiansen @devchristiansenRead More
One of my favorite and first digital health companies I came to know is Proteus Digital Health. When I discovered what they were working on some time ago, I was quickly both seduced and awestruck. “No way…a smart pill?...this has to be made up” was probably my first thought – like the fake Pied Piper landing page for the HBO series Silicon Valley – but unbelievably, the company was real, with FDA plus European Commission approval and all. And my mind was blown.I’ve spent the bulk of my career in healthcare (including healthcare services and medical devices) and love it for many reasons. But discovering Proteus was an aHA! that really got me thinking deeper about the power and possibility of health + technology and helped inspire me to expand my focus to startups in the digital health space. To this day, when someone asks me “what is digital health?”, I generally describe it by way of an example and frequently mention Proteus as that example. It normally is received with both ooouus and ahhhhs. Anyway, given my *arms-length crush, I was happy when Proteus recently gained mass “darling status” after completing the last piece of a $172M fundraising round at the end of July. This makes them one of the most well-funded private digital health companies out there at the moment and adds them to the speculative short-list of “who will be next to IPO in digital health?” No doubt very exciting for them...but I'm sure they'd be the first to say their work has just begun as they help to move digital medicine to the mainstream. *Note: I have no affiliation with the companyOk, ok, so what makes Proteus Digital Health so cool? What do they actually do?To first categorize, they are a digital medical device and remote care management company - with overlap in the internet of things sector - and they produce a 'digital [medicine] feedback system'. This is comprised of a tiny organic ingestible sensor that people swallow with (or in) their medication. This sensor contains trace amounts of copper and magnesium that react and send a wireless signal to a disposable battery powered patch (which they also produce) which sticks to one's abdomen. This patch reports data wirelessly to the cloud and provides information on if/when medications have been taken and also aggregates rest and activity patterns. Pretty cool, eh? It's the stuff out of science fiction - understanding your body from the inside out! There is a video on their website which summarizes this process nicely as well if you are more of a visual person.Overall, Proteus empowers caregivers to ensure patients are both taking medication and taking it properly. Medication non-adherence can lead to readmissions and chronic illness which both are key drivers of increased healthcare costs. Proteus' simple value proposition is that their products reduce the incidence of non-adherence, which ultimately saves healthcare providers and insurers LOTS OF MONEY. Cha-ching! Oh, and let's not forget it helps patients live healthier, happier lives too.The whole concept is quite brilliant in my opinion - anything that can promote quality outcomes and help to reduce costs in the soaring cost environment that is healthcare is a relatively frictionless sell (Note: Proteus is currently in private beta with a handful of US health systems and working with some prominent pharmaceuticals as well). A large volume of other digital health startups are attacking the US high cost / low quality healthcare epidemic from different angles. A few examples being: improving communication and clinical workflow, adopting teleHealth technologies and leveraging electronic health records.Thanks Proteus for the personal inspiration - onward and [email protected] - For all the deep clinical information you can handle on their ingestible sensor, check out this paper.Read More
Recently there has been a lot of media attention around the newest class of startups picked to participate in the New York Digital Health Accelerator’s (NYDHA) second class (announced July 22 2014). Before unraveling this, let’s first set the scene. 1) Digital Health is off to a record breaking start in 2014 with VC investment pouring in at a breakneck pace – $2.3B through June 30th – and 2) additionally, there has been a proliferation of Digital Health specific accelerator and incubator programs over the past few years – the stars being Rock Health and Blueprint Health (see expanded list of accelerators @ VentureScanner). It is safe to say there are A LOT of eyes on Digital Health and the ground for health tech entrepreneurs is the more fertile than ever. Resources are abundant.
This week I came across a very thought-provoking report recently released by the Vitality Institute that provides recommendations on the promotion of health and prevention of chronic disease for working-age Americans. There is a lot of insightful detail (I highly recommend having an extended peek), but in sum, the Commission developed evidence empirically linking the health of the US’ workforce to the long-term competitiveness of the US economy – the proposition: unhealthy workforce = unhealthy economy. Said another way, lower worker productivity and soaring US healthcare costs ($2.7T or 17.7% of US GDP in 2011 – the below graphic provides perspective on magnitude) impede innovation and reduce overall investment in education and R&D.
With the changing legislative and regulatory landscape in the US over the past many years, there has been a lot of talk around the emergence of Accountable Care Organizations (ACOs - defined below) and the greater role they will play in the future. Hopes are high that these organizations can help to right some of the compounded wrongs in the industry. First things first, I think it is useful for us all to gain some greater clarity behind what an ACO is – a term that is still relatively new to most of us, having first been coined in 2006.
It’s no surprise - advances in health care and medical technology are extending life expectancies worldwide. Humans are simply living longer, and although this is generally good news for human kind, it increases macro pressure on health care systems and social programs. In challenge lies opportunity – enter digital health - but we’ll table that for now.
I currently am tracking 509 Digital Health companies across 21 categories, with combined funding of $7.05B. Digital Health is an extensive and evolving term, but simply stated, it is the application of digital technologies to enhance both personal health and the delivery of healthcare. These companies all focus on using emerging technologies to deploy solutions across the entire health ecosystem - from individual consumer to healthcare provider to employer to large hospital system, from biometric sensors to genomics to mobile connectivity to cloud computing.